儿童初发激素敏感性肾病综合征唾液监测泼尼松龙可行性研究
本研究基于一项左旋咪唑随机安慰剂对照试验,在39例初发激素敏感性肾病综合征患儿中描述未结合型泼尼松龙在血浆和唾液中的药代动力学特征。采用非线性混合效应模型估算参数,并利用蒙特卡洛模拟评估唾液监测的预测性能。结果显示唾液与血浆比值典型值为1.30,基于4份唾液样本和1份血浆样本可在79%患者中以20%以内不精密度预测未结合型血浆AUC。
要点
- 唾液与血浆未结合型泼尼松龙比值典型值为1.30(相对平方误差8%)。
- 基于4份唾液和1份血浆样本,79%患儿可20%以内不精密度预测血浆暴露。
- 唾液监测是儿童激素敏感性肾病综合征患者友好且可靠的泼尼松龙暴露评估选项。
核心结论
- 唾液被证明是确定儿童激素敏感性肾病综合征患者泼尼松龙血浆暴露的可靠且患者友好的选择。
研究设计与样本
- 研究纳入39例2-16岁初发激素敏感性肾病综合征患儿,来自一项左旋咪唑随机安慰剂对照试验,接受18周泼尼松龙逐渐减量方案。
- 在首次发病后第4周(唾液)和第8周(唾液和血浆)各采集5份系列样本,共获得109份血浆和275份唾液样本。
- 采用非线性混合效应模型估算未结合型泼尼松龙的药代动力学参数及唾液-血浆比值,并运用蒙特卡洛模拟评估唾液监测的预测性能。
主要发现
- 未结合型泼尼松龙血浆清除率估计值为93(相对平方误差5%)L h-1 70 kg-1,分布容积为158(7%)L 70 kg-1。
- 唾液与血浆比值典型值为1.30(8%)。
- 蒙特卡洛模拟显示,基于4份唾液样本和1份血浆样本,可在79%患者中以20%以内不精密度预测未结合型血浆浓度-时间曲线下面积,而基于4份血浆样本为87%。
临床怎么用
- 唾液监测可作为儿童激素敏感性肾病综合征患者泼尼松龙血浆暴露评估的患者友好型替代方法。
- 该研究为在多种儿科疾病中进一步开展泼尼松龙药代动力学和药效学研究提供了机会。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Prednisolone is the cornerstone of treatment for idiopathic nephrotic syndrome in children, but is associated with marked side-effects. Therapeutic drug monitoring using saliva would be a patient-friendly option to monitor prednisolone treatment. To assess the feasibility of saliva monitoring, we described the pharmacokinetics (PK) of unbound prednisolone in plasma and saliva of children with first onset steroid-sensitive nephrotic syndrome (SSNS). METHODS: Children (age 2-16 years) with SSNS participating in a randomized, placebo-controlled trial with levamisole were treated with an 18-week tapering schedule of prednisolone. Five serial samples were collected at 4 (saliva) and 8 weeks (saliva and plasma) after first onset. A nonlinear mixed-effects model was used to estimate the PK parameters of unbound prednisolone and the saliva-to-plasma ratio. Monte Carlo simulations were performed to assess the predictive performance of saliva monitoring. RESULTS: From 39 children, 109 plasma and 275 saliva samples were available. Estimates (relative squared error) of unbound plasma clearance and volume of distribution were 93 (5%) L h-1 70 kg-1 and 158 (7%) L 70 kg-1, respectively. Typical saliva-to-plasma ratio was 1.30 (8%). Monte Carlo simulations demonstrated that on basis of 4 saliva samples and a single plasma sample unbound plasma area-under-the-concentration-time curve can be predicted within 20% imprecision in 79% of the patients compared to 87% based on 4 plasma samples. CONCLUSION: Saliva proved to be a reliable and patient-friendly option to determine prednisolone plasma exposure in children with SSNS. This opens opportunities for further PK and pharmacodynamics studies of prednisolone in a variety of paediatric conditions.
引用
- Veltkamp F, Pistorius MCM, Mak-Nienhuis EM, et al. Saliva monitoring of prednisolone in children with first onset steroid-sensitive nephrotic syndrome: Is it possible? Br J Clin Pharmacol. 2024. PMID: 38599658. doi:10.1111/bcp.16066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。